Literature DB >> 20425852

Identifying barriers to treatment adherence and related attitudinal patterns in adolescents with cystic fibrosis.

Eric J Dziuban1, Lisa Saab-Abazeed, Sarah R Chaudhry, Daniel S Streetman, Samya Z Nasr.   

Abstract

INTRODUCTION: The treatment of cystic fibrosis (CF) is directed toward correction of organ dysfunction and relief of symptoms resulting from the disease. Lack of adherence to daily treatment regimens may have substantial short-term and long-term effects on patients with CF. In this study, we attempted to identify barriers to treatment adherence which could be predicted by objective measures and explore ways to improve adherence in adolescents with CF.
METHODS: A questionnaire was given to patients 12.0-20.9 years of age, designed with focus on specific barriers to adhering to treatment plan and related attitudinal patterns. Observational and analytical results were collected.
RESULTS: We obtained questionnaires and objective health data for 60 respondents. The most commonly identified barriers to adherence were forgetting or losing medications (32/60) and being too busy (23/60). Attitudinal patterns that played a significant role for nonadherence included unintentional forgetting (40/60), feeling that following CF treatments resulted in less freedom in their lives (30/60), and believing it is acceptable to miss a treatment every few days (18/60) or to miss treatments when busy (18/60). DISCUSSION: There were a few statistically significant differences of adherence patterns between demographic subgroups in our study. Males were more likely to agree that it is acceptable to miss doses if they are made up with extra doses later (24% vs. 3%, P = 0.04). Patients who perceived themselves to be less healthy agreed more to statements of limited freedom, nonsympathetic medical providers, and difficulty adhering during times of decreased symptoms. This highlights an unexpected risk: as CF progresses and patients perceive themselves to be less healthy, they may become less likely to be adherent during the periods they are feeling the best, while at the same time becoming less likely to perceive empathy from their physicians.
CONCLUSIONS: Survey results describe a variety of beliefs and attitudinal patterns which contribute to nonadherence in CF treatment, especially relating to time management. While patients largely understood the importance of treatments to their health, predictors of risky behaviors could lead to targeted interventions by CF centers to address these challenges and improve adherence.

Entities:  

Mesh:

Year:  2010        PMID: 20425852     DOI: 10.1002/ppul.21195

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  24 in total

1.  Answering the call to address cystic fibrosis treatment burden in the era of highly effective CFTR modulator therapy.

Authors:  Alex H Gifford; Nicole Mayer-Hamblett; Kelsie Pearson; David P Nichols
Journal:  J Cyst Fibros       Date:  2019-11-21       Impact factor: 5.482

2.  Greater number of perceived barriers to hydroxyurea associated with poorer health-related quality of life in youth with sickle cell disease.

Authors:  Arlene Smaldone; Deepa Manwani; Nancy S Green
Journal:  Pediatr Blood Cancer       Date:  2019-04-02       Impact factor: 3.167

3.  Motivating adherence among adolescents with cystic fibrosis: youth and parent perspectives.

Authors:  Gregory S Sawicki; Karen S Heller; Nathan Demars; Walter M Robinson
Journal:  Pediatr Pulmonol       Date:  2014-03-10

Review 4.  The coming of age of adolescent rheumatology.

Authors:  Despina Eleftheriou; David A Isenberg; Lucy R Wedderburn; Yiannis Ioannou
Journal:  Nat Rev Rheumatol       Date:  2014-01-07       Impact factor: 20.543

5.  Factors affecting nebulised medicine adherence in adult patients with cystic fibrosis: a qualitative study.

Authors:  Alice Hogan; Mary-Ann Bonney; Jo-Anne Brien; Rita Karamy; Parisa Aslani
Journal:  Int J Clin Pharm       Date:  2014-11-29

6.  Perceptions of barriers and facilitators: self-management decisions by older adolescents and adults with CF.

Authors:  Maureen George; Devin Rand-Giovannetti; Michelle N Eakin; Belinda Borrelli; Melissa Zettler; Kristin A Riekert
Journal:  J Cyst Fibros       Date:  2010-09-16       Impact factor: 5.482

7.  Development and validation of CF-Medication Beliefs Questionnaire: A mixed-methods approach.

Authors:  Michelle N Eakin; Shang-En Chung; Jessica Hoehn; Belinda Borrelli; Devin Rand-Giovannetti; Kristin A Riekert
Journal:  J Cyst Fibros       Date:  2017-05-23       Impact factor: 5.482

8.  Management issues for adolescents with cystic fibrosis.

Authors:  Adelaide Lindsay Withers
Journal:  Pulm Med       Date:  2012-09-06

9.  Determinants of antiretroviral therapy adherence in northern Tanzania: a comprehensive picture from the patient perspective.

Authors:  Ramsey A Lyimo; Marijn de Bruin; Jossy van den Boogaard; Harm J Hospers; André van der Ven; Declare Mushi
Journal:  BMC Public Health       Date:  2012-08-30       Impact factor: 3.295

10.  Barriers to adherence in adolescents and young adults with cystic fibrosis: a questionnaire study in young patients and their parents.

Authors:  Vibeke Bregnballe; Peter Oluf Schiøtz; Kirsten A Boisen; Tacjana Pressler; Mikael Thastum
Journal:  Patient Prefer Adherence       Date:  2011-10-11       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.